🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 17 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/11/2010 | 33,30 | 33,79 | 33,25 | 33,60 | +0,71% | 1,60% | 14.792.939 |
| 10/11/2010 | 33,44 | 33,57 | 33,19 | 33,36 | -0,26% | 1,14% | 19.982.216 |
| 09/11/2010 | 33,92 | 34,10 | 33,38 | 33,44 | -1,60% | 2,14% | 22.320.933 |
| 08/11/2010 | 34,02 | 34,17 | 33,94 | 33,99 | -0,22% | 0,67% | 14.344.186 |
| 05/11/2010 | 34,99 | 35,06 | 33,80 | 34,06 | -2,59% | 3,60% | 23.583.144 |
| 04/11/2010 | 35,17 | 35,26 | 34,77 | 34,97 | +0,38% | 1,38% | 12.430.433 |
| 03/11/2010 | 35,05 | 35,09 | 34,39 | 34,84 | -0,27% | 1,99% | 9.966.690 |
| 02/11/2010 | 34,90 | 35,17 | 34,84 | 34,93 | +0,99% | 0,96% | 10.462.813 |
| 01/11/2010 | 34,77 | 35,05 | 34,33 | 34,59 | -0,17% | 2,06% | 10.131.540 |
| 29/10/2010 | 35,05 | 35,06 | 34,37 | 34,65 | -1,71% | 1,96% | 15.961.669 |
| 28/10/2010 | 34,99 | 35,36 | 34,98 | 35,25 | +1,32% | 1,09% | 10.344.074 |
| 27/10/2010 | 35,19 | 35,19 | 34,48 | 34,79 | -1,65% | 2,03% | 12.701.131 |
| 26/10/2010 | 35,60 | 35,62 | 35,20 | 35,37 | -0,94% | 1,18% | 7.444.363 |
| 25/10/2010 | 35,59 | 35,95 | 35,58 | 35,71 | +0,86% | 1,05% | 11.167.488 |
| 22/10/2010 | 35,37 | 35,45 | 35,26 | 35,40 | +0,00% | 0,54% | 6.634.469 |
| 21/10/2010 | 35,40 | 35,45 | 34,90 | 35,40 | +0,30% | 1,54% | 10.870.904 |
| 20/10/2010 | 34,93 | 35,54 | 34,90 | 35,30 | +1,29% | 1,86% | 10.133.426 |
| 19/10/2010 | 35,31 | 35,35 | 34,65 | 34,85 | -1,91% | 2,00% | 10.869.961 |
| 18/10/2010 | 35,22 | 35,53 | 35,22 | 35,52 | +0,76% | 0,89% | 11.109.953 |
| 15/10/2010 | 35,56 | 35,73 | 35,08 | 35,26 | -0,54% | 1,82% | 15.746.619 |
| 14/10/2010 | 35,56 | 35,67 | 35,15 | 35,45 | -0,03% | 1,45% | 10.002.531 |
| 13/10/2010 | 35,17 | 35,68 | 35,10 | 35,46 | +1,42% | 1,66% | 10.230.890 |
| 12/10/2010 | 34,99 | 35,13 | 34,66 | 34,96 | -0,60% | 1,36% | 11.570.339 |
| 11/10/2010 | 35,17 | 35,31 | 34,99 | 35,17 | -0,14% | 0,90% | 5.843.858 |
| 08/10/2010 | 35,13 | 35,30 | 34,93 | 35,22 | +0,54% | 1,03% | 9.097.478 |
| 07/10/2010 | 35,64 | 35,68 | 34,95 | 35,03 | -0,81% | 2,03% | 14.564.894 |
| 06/10/2010 | 35,34 | 35,52 | 35,13 | 35,31 | -0,03% | 1,08% | 7.903.282 |
| 05/10/2010 | 35,17 | 35,45 | 35,02 | 35,32 | +1,37% | 1,22% | 11.181.322 |
| 04/10/2010 | 34,82 | 35,07 | 34,63 | 34,85 | -0,22% | 1,26% | 9.678.175 |
| 01/10/2010 | 35,08 | 35,15 | 34,69 | 34,92 | -0,57% | 1,33% | 12.305.511 |